-
Uncategorized2 months agoSTAT+: Maryland state affordability board sets its first price cap for a medicine
Seeking to cap the cost of medicines, the Maryland Prescription Drug Affordability Board set an upper payment limit for a widely prescribed diabetes treatment, marking only...
-
Uncategorized2 months ago
4D whole-cell model of a minimal cell
Post Content
-
Uncategorized2 months ago
Fast and accurate multiple-protein-sequence alignment at scale with FAMSA2
Nature Biotechnology, Published online: 14 April 2026; doi:10.1038/s41587-026-03095-3 FAMSA2 accurately aligns millions of protein sequences at high speed.
-
Uncategorized2 months agoSTAT+: FDA pushes drugmakers to report missing clinical trial results
In a bid toward greater transparency, the Food and Drug Administration sent reminder letters to more than 2,200 companies and researchers that they are required to...
-
Uncategorized2 months agoSTAT+: Federal judge tosses California No Surprises Act lawsuit against HaloMD
A federal judge has tossed one of the four pending civil lawsuits against HaloMD, a company that represents providers in No Surprises Act arbitration cases. The...
-
Uncategorized2 months ago
Click Therapeutics cuts 27% of workforce after $50M raise
Click Therapeutics cuts 27% of workforce after $50M raise
-
Uncategorized2 months agoSex-Related Differences in Immune System Aging May Impact Disease Susceptibility
Immune system aging, known as immunosenescence, is associated with changes in immune cell composition and function that increase susceptibility to disease. The results of a study...
-
Uncategorized2 months ago
White House policies are ‘incredibly worrisome’ for small biotechs, Rhythm CEO says
Biotechs with single products in the market are likely on edge about how President Donald Trump’s pharma tariffs and “most favored nation” pricing will play out,...
-
Uncategorized2 months agoSTAT+: Access granted: CMS greenlights more than 150 participants for chronic care experiment
More than 150 companies and providers have been provisionally approved to participate in an experimental Medicare program meant to expand access to technology-supported chronic care. They...
-
Uncategorized2 months ago
FDA narrows in on search for new biologics and vaccines leader
The FDA is getting closer to announcing a director of the Center for Biologics Evaluation and Research, sources told Endpoints News, following the controversial tenure of...
STAT+: At hospital finance conference, a call to end the friction that’s keeping costs high
Beyond sunshine: Iberia’s biotech moment has arrived with developing capital networks
